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Abstract
Background: PCR based diagnosis for Visceral Leishmaniasis (VL), despite numerous published primers, remains far from
being applied in the field. The present study was planned to design a Leishmania specific diagnostic assay and to evaluate
its sensitivity and specificity on a sample size, which to the best of our knowledge is the largest ever screened in one study.
Methods: Leishmania specific primers were developed using 18S rRNA gene and their sensitivity was evaluated on 500
parasitologically confirmed patients with VL and 25 Post Kala-azar Dermal Leishmaniasis (PKDL) patients. Specificity was
calculated on 250 healthy endemic controls, 250 healthy non endemic controls and 250 non leishmanial diseases like
malaria.
Results: Our PCR assay had a sensitivity of 87.8% (95%CI: 84.1–89.8) using 200 mL of patient’s peripheral-blood. Specificity
was absolute in non-endemic healthy controls and in subjects with different diseases while in endemic controls it was 84%
(95%CI: 78.9–88.0). Its overall specificity was 94.6% (95%CI-92.8–96.1).
Conclusions: The PCR assay developed is sensitive enough to detect the 18S rRNA gene in an amount equivalent to a single
parasite or less in a one million human cell environment. The high sensitivity of this PCR diagnostic test with relatively non-
invasive peripheral blood sampling method opens up the possibility of its deployment in field for the routine diagnosis of
VL.
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Introduction
The gold standard for the diagnosis of Visceral Leishmaniasis
(VL) is demonstration of parasites (amastigotes) in giemsa-stained
smears prepared from splenic or bone marrow aspirates [1]. Splenic
smears have high sensitivity, but are associated with a risk of
serious/fatal haemorrhage, while bone marrow smears have low
sensitivity and the procedure is painful [2]. Serological tests like the
direct agglutination test (DAT), rK39 immunochromatographic
tests and the Indirect Immunofluorescent Antibody Test all have
high sensitivity but cannot discriminate between past and current
infections [2,3,4]. Molecular diagnosis exploiting PCR combines
several advantages; it is minimally invasive, has a high sensitivity
and specificity, is capable of identifying relapses and reinfections in
treated VL patients, and can provide species identification [5,6].
Many different PCR assays have targeted conserved and variable
regions of kDNA minicircles [7,8,9,10,11], genomic DNA, splice
leader mini-exon (SLME) [12], telomeric repeats [13], rRNA gene
[14] and gp63 [15] for the detection of parasites directly from
human tissues. However, despite countless reports describing PCR
in VL diagnosis, none of these assays are used as a diagnostic tool in
clinical setting. The aim of this study was to develop a PCR assay,
with a view to assess its robustness in large sample size, and develop
a suitable field version for studies performed in endemic regions.
Materials and Methods
Study Site, Patients and Controls
The study was approved by the Institutional Ethical Committee
of Institute of Medical Sciences (IMS), Banaras Hindu University
(BHU), Varanasi and a written informed consent was obtained
from all subjects. The study was conducted between January 2007
and December 2009. Parasitologically confirmed VL patients
(n=500) were recruited from the field site Kala Azar Medical
Research Centre (KAMRC) at Muzaffarpur, Bihar and Sir
Sundarlal Hospital, Banaras Hindu University, Varanasi. Twenty
five Post Kala-azar Dermal Leishmaniasis (PKDL) patients were
also included in the study. Controls included 250 healthy controls
belonging to endemic areas with active transmission of VL (EHC),
250 healthy controls coming from regions not endemic for VL
(NEHC), and 250 patients with common infectious diseases like
Malaria, TB (Different Diseases) were also included in the study to
evaluate the specificity of the assay.
Sample collection, storage, and DNA preparation
Peripheral blood samples (1–2 ml) were collected in heparin
vacutainers and stored at 4uC. The samples were transported at
4uC from KAMRC, Muzaffarpur to BHU where they were
processed within a week. DNA was isolated from 200 ml peripheral
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the manufacturer’s instructions. All the samples were quantified
using picodrop spectrophotometer (Picodrop Limited, UK),
aliquoted in triplicates to avoid DNA damage during repeated
freeze thawing and stored at 220uC. DNA preparations were also
made from Leishmania donovani promastigotes using the QIAamp
DNA Mini Kit (Qiagen). The parasitic DNA was diluted in 10 fold
serial dilutions starting from 1000 ng upto .001 pg.
Preparation of spiked samples
Freshly drawn peripheral blood from a healthy volunteer was
used to prepare spiked samples in triplicate for each dilution. L.
donovani promastigotes ranging from 10,000 to 100 parasites were
spiked in 200 ml of blood in a 10 fold dilution. Counting of
parasites was performed using a haemocytometer. For spiking 10
and 1 parasite, the hanging drop method was used. Pre- dilution of
the parasites in 2 ml cRPMI media was made and a microdrop of
it was put on the cavity slide using sterile glass micropipette. The
slide was sealed with the coverslip and sealing media to prevent
drying of the drop. Several dilutions were tested till we could see a
single parasite in the drop under an inverted microscope which
was then spiked into 200 ml of blood. DNA from these spiked
samples was isolated using QIAamp DNA Blood Mini Kit
(Qiagen) and quantified in a similar way as described above.
Primer designing
Since primers are of crucial importance to the success of any
diagnostic PCR assay, a rigorous bioinformatics analysis was done.
The 18S rRNA gene was chosen as the target region because it is a
multicopy gene and is present in 50–200 copies per Leishmania
genome. 18S rRNA gene sequences from L. donovani (GenBank
Accession ID X0773), T b. gambiense (AJ009141) and T. cruzi
(AF303660) were aligned using ClustalW softwareversion 2 (http://
www.ebi.ac.uk/Tools/clustalw2) (Figure 1) and primers were
designed using the most stringent conditions allowed in the software
package against the conserved regions by using OLIGO4 primer
analysis software. At least 3–4 mismatches at 39 end of both forward
and reverse primers were ensured within the aligned sequences to
ascertain that the primers do not show any cross reactivity with
closely related trypanosomatids. The forward primer, designated as
BHUL18SF (59 CGTAACGCCTTTTCAACTCAC 39)a n d
reverse primer as BHUL18SR (59 GCCGAATAGAAAAGA-
TACGTAAG 39), amplify a region of 311 bp. The specificity of
the primers was examined using the BLAST programme at NCBI
site. In silico PCR was performed using UCSC genome browser
(http://genome.ucsc.edu/) to be confident that the primers do not
show any cross reactivity with human sequences. The primers were
synthesized by Metabion, Germany.
PCR optimization
PCR was first optimised using parasitic DNA and then on clinical
samples. The reaction mixture (25 mL) contained 16 Taq
Polymerase Buffer (Promega), 1.5 mM MgCl2, 200 mM concentra-
tion of each deoxynucleotide triphosphate (dNTP), 5 pmole of each
primer, 1.5 U of Taq DNA Polymerase (Promega) and 150 ng of
template. The annealing temperature of the primers was deter-
mined by setting up a temperature gradient PCR (Veriti, ABI,
Foster City, USA) in increments of 2uC starting from 52uC. The
reaction mixture using primer BHUL18SF/R was amplified in ABI
Gene Amp PCR System 9700 (ABI, Foster City, USA) with heated
lidoptionat95uCfor4 minfollowed by40cycles,eachconsistingof
45 secs at 94uC, 45 secs at 62uC, and 1 min at 72uC, and a final
extension step of 5 min at 72uC. Products were analysed by
electrophoresis on 1.5% agarose (Thermo Scientific, Mol Bio
Grade) gel, containing ethidium bromide (0.5 mg/ml in TAE
buffer), 0.04 M Tris acetate, 0.001 M EDTA and photographed
under UV illumination and bands quantified by using Gel
documentation software (Alfa Innotech Corporation, San Leo-
nardo, CA, USA). For each experiment, multiple numbers of
negativecontrolswere includedtocheckforpossiblecontamination.
Figure 1. Sequence alignment and primer designing. Alignment of the DNA sequence within the 18S rRNA gene of Leishmania donovani (L.d.;
GenBank accession no. X07773), Trypanosoma brucei gambiense (T.b.; GenBank accession no. AJ009141), and Trypanosoma cruzi (T.c.; GenBank
accession no. AF303660). The forward (BHUL18SF) and reverse (BHUL18SR) primers are indicated by arrows.
doi:10.1371/journal.pone.0019304.g001
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The PCR amplification products from culture isolates and clinical
samples from patients with VL and PKDL were cloned into the
pGEMT-Easy vector system (Promega). The amplified PCR product
was purified from gel using Sigma Gel elute columns. Sequencing
PCR was conducted using a Thermo Sequenase premixed ABI
BigDye Terminator 3.1 cycle sequencing kit (Applied Biosystems,
Inc., Foster City, CA) according to the manufacturer’s instructions
under following conditions: first heating at 96uCf o r1m i na n dt h e n
30 cycles consisting of 96uCf o r1 0s e ca n d5 0 uC for 10 sec, 60uCf o r
30 sec and 60uC for 4 min. After ethanol precipitation and
purification, the sequencing samples were loaded to ABI3130 genetic
analyser. Sequence analysis was done by Chromas software.
Results
Detection limit of optimised PCR assay with BHUL18S
primer
Sensitivity analysis of primer BHUL18S with serially diluted
parasitic DNA showed that the lower limits of detection of
developed PCR assay was 100 fg. The results with spiked blood
samples showed that the assay was sensitive enough to detect down
to 1 parasite spiked per 200 ml of blood (Figure 2).
Evaluation in Clinical Samples
Of the 500 parasitologically confirmed clinical samples, 439 were
PCR positive with BHUL18S primer (Figure 3). The test provided
successful diagnosis of VL with 87.8% (95% CI: 84.1–89.8) sensitivity
using patient’swhole peripheral blood (Table 1).In endemic controls,
the specificity was 84% (95% CI: 78.9–88%) (Table 2). None of the
250 nonendemic controls were positive and thus, the specificity in this
group was 100% (95% CI: 98.5–100). The data from the different
disease group also showed 100% (95% CI: 98.5–100) specificity as
none of the 250 non-leishmanial disease samples were PCR positive.
The overall specificity was 94.6% (95% CI: 92.8–96.1).
Nucleotide BLAST analysis after sequencing of PCR products
obtained from clinical samples, as well as from parasite isolates,
revealed that there was 100% identity with the 18S rRNA gene of
L. donovani and no identity to human rRNA or Plasmodium sp,
Mycobacterium etc.
Figure 2. PCR result for spiked samples. Lane 1–3: 10,000 parasites, Lane 4–6: 1000 parasites, Lane 7–9: 100 parasites, Lane 10–12: 10 parasites,
Lane 13–15: 1 parasite, Lane 16–18: No Template controls (NTC), M=100 bp marker.
doi:10.1371/journal.pone.0019304.g002
Figure 3. PCR results in clinical samples. Lanes H1and H2: Non-endemic healthy controls, Lane N1 and N2: negative controls, Lanes P1 to P8: VL
patients, M=100 bp marker.
doi:10.1371/journal.pone.0019304.g003
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The study was initiated to develop, as well as evaluate the
sensitivity and specificity of the designed primers in a PCR assay in
peripheral blood samples from VL patients. To our knowledge, this
study has validated the largest number of patients and controls for
diagnosis of VL through PCR. We looked at the critical points
affecting the success of a diagnostic PCR and standardized and
optimized the protocols leading to development of a PCR assay
which may be used for routine diagnosis in endemic regions of
Bihar. Currently the molecular diagnosis of VL solely relies on PCR
based assays of various throughputs, extensively reviewed by
Reithinger et al [16]. Recently chromatography based Oligo-C test
and NASBA have been introduced [17] and their sensitivity and
specificity was determined in Sudan [18], East Africa [19] and
Kenya [20] in clinical samples from VL patients. However, none of
them are yet an option for diagnosis in Indian clinical settings
because of the lack of standardisation and the insufficient sample
size included in the experiments. Our study, which involves normal
qualitative PCR in diagnosis of VL, has been validated on a large
sample size wherein lies its significance. The PCR reaction
conditions were thoroughly optimized and consistent results were
obtained. The rRNA gene which has a copy number of 50–200 was
chosen and we were able to reach high sensitivities of 87.8%. The
12.8%negative patientsmayhavehad very lowcirculating parasites
in blood leading to negative PCR. In the clinical setting, if there is a
negative PCR result and a highlevel of clinical suspicion, then other
methods of detection such as splenic aspiration or serology could be
used [21]. Since the sensitivity and specificity of any PCR assay
depends on many factors, precautions were taken at each and every
step starting from sample collection till DNA isolation. Strict
measures like complete separation of pre PCR and post PCR
regions, 3–4 negative controls with each set of experiment helped in
achieving the high specifity level. Until now, apart from in research
settings, in most endemic regions in Indian subcontinent, surrogate
markers involving anti- rK39 rapid tests is being used for diagnosis,
where up to 30% of endemic controls, and 2–3% of subjects with
difference diseases like malaria or tuberculosis may test positive.
Molecular based tests are more specific as in our study none of
patients with other diseases tested positive. However, a 16% PCR
positivity in healthy endemic controls was obtained. This reinvig-
orates the prevalence of asymptomatic individuals who harbor
Leishmania parasites without developing clinical symptoms. This is a
consistent finding with many different types of diagnostic test in the
context of the endemic healthy population [22,23]. Since
undetected and untreated infections can continue the chain of
transmission and can lead to serious long-term complications, tests
to screen individuals for such asymptomatic infections might reduce
disease transmission in the community and hence can be an added
advantage of the developed assay. The developed assay is not
species specific since SSU rRNA gene is highly conserved within
Leishmania species. However, this is not a drawback since it is well
established that L. donovani is the only causal agent of VL in Indian
subcontinent.
Whether PCR will eventually replace the gold standard of
parasite demonstration and serology based detection is a
controversial question. The overall cost calculated for one PCR
assay starting from DNA isolation in this study was minimal, only
Rs 230 (less than $5) which is quite similar to cost of one rk39 strip.
A basic molecular biology lab with minimum infrastructure; a
thermocycler, a UV transilluminator and a gel electrophoresis unit
are a onetime investment and if they can be provided, PCR could
be performed in an endemic setting for routine diagnosis.
In conclusion, we report here the results of a PCR study with
high sensitivity and specificity. The present study is robust as it was
performed on a large sample size over two years with remarkable
consistency. The next step would be to decentralize this technique
to at least district level especially in the endemic areas where one
PCR laboratory with capability to perform PCR could obviate the
need of risky procedures like splenic aspirate and provide a more
specific diagnosis than the currently used surrogate markers.
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